Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
Journal of Neuroimmunology|July 1, 1993
Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjectsJ M van Noort, A van Sechel, J Boon, et al.
Magnetic Resonance in Medicine|January 29, 2005
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matterH Vrenken, F Barkhof, B M J Uitdehaag, et al.
Journal of Neuroimmunology|January 1, 1995
Analysis of CD27 surface expression on T cell subsets in MS patients and control individualsR Q Hintzen, U Fiszer, S Fredrikson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2014
Detecting clinically-relevant changes in progressive multiple sclerosisL V A E Bosma, J M Sonder, J J Kragt, et al.
Neurology|March 23, 2005
Interferon beta-1b treatment does not induce autoantibodiesC H Polman, L Kappos, F Dahlke, et al.
Journal of Chromatography|February 7, 1992
Determination of 4-aminopyridine in serum by solid-phase extraction and high-performance liquid chromatographyA van der Horst, P N de Goede, H A van Diemen, et al.
Neuroscience Letters|July 24, 2003
Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patientsC E Teunissen, C D Dijkstra, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2011
Community walking can be assessed using a 10-metre timed walk testJ C E Kempen, V de Groot, D L Knol, et al.
Journal of Neurology|September 25, 2001
Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injuryM A van der Bruggen, H B Huisman, H Beckerman, et al.
Neurology|January 11, 2008
Responsiveness and predictive value of EDSS and MSFC in primary progressive MSJ J Kragt, A J Thompson, X Montalban, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neuroimmunology|July 1, 1993
Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjectsJ M van Noort, A van Sechel, J Boon, et al.
Magnetic Resonance in Medicine|January 29, 2005
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matterH Vrenken, F Barkhof, B M J Uitdehaag, et al.
Journal of Neuroimmunology|January 1, 1995
Analysis of CD27 surface expression on T cell subsets in MS patients and control individualsR Q Hintzen, U Fiszer, S Fredrikson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2014
Detecting clinically-relevant changes in progressive multiple sclerosisL V A E Bosma, J M Sonder, J J Kragt, et al.
Neurology|March 23, 2005
Interferon beta-1b treatment does not induce autoantibodiesC H Polman, L Kappos, F Dahlke, et al.
Journal of Chromatography|February 7, 1992
Determination of 4-aminopyridine in serum by solid-phase extraction and high-performance liquid chromatographyA van der Horst, P N de Goede, H A van Diemen, et al.
Neuroscience Letters|July 24, 2003
Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patientsC E Teunissen, C D Dijkstra, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2011
Community walking can be assessed using a 10-metre timed walk testJ C E Kempen, V de Groot, D L Knol, et al.
Journal of Neurology|September 25, 2001
Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injuryM A van der Bruggen, H B Huisman, H Beckerman, et al.
Neurology|January 11, 2008
Responsiveness and predictive value of EDSS and MSFC in primary progressive MSJ J Kragt, A J Thompson, X Montalban, et al.
Pageof 29